Consequently, we overexpressed PAX1 in two cervical cancer cell lines, HeLa and SiHa, and found that it did not significantly inhibit malignant phenotypes, including proliferation, migration, and invasion, in vitro, and tumor growth, in vivo (Fig. 1C–F). This evidence concerns the gene PAX1 and cervical carcinoma.